Vol.

No.

April 03, 2026Apr 03, 2026

DOWNLOAD THE PDF

HHS presents new protein-forward dietary guidelines, turning the food pyramid upside down The Kennedy guidelines are mum on cancer risks associated with red meat and alcohol

Cover Story

News Analysis

HHS presents new protein-forward dietary guidelines, turning the food pyramid upside down

The Kennedy guidelines are mum on cancer risks associated with red meat and alcohol

By Claire Marie Porter

Recently, HHS Secretary Robert F. Kennedy Jr. posted a video montage featuring himself shirtless in jeans, working out with Kid Rock. The duo is in a blue-lit grotto with a cold plunge and sauna. Set to Kid Rock’s “Bawitdaba” and intercut with a selection of patriotic imagery, the video ends with the two men in a hot tub, chugging what appears to be milk.

Free

Ukrainian oncologists press on in year four of wartime disruptions
Amid missiles and blackouts, “you cannot put your life on a pause forever.”

By Sara Willa Ernst

Guest Editorial

FDA’s guidance on MRD in MM goes beyond the ODAC vote—and that’s where it matters most
Draft guidance consolidates trial design updates for developers

By Nicholas Richardson

Editorial

The Cancer Letter Podcast nominated for 30th annual Webby Awards

By Paul Goldberg and Jacquelyn Cobb

Cancer Policy

NCI slated to get a $9 million raise as Trump’s budget proposes about 10% cut for NIH

Trump imposes up to 100% tariff on some brand name pharmaceutical companies

Radiation oncologists hit hard after Medicare cuts, ASTRO survey finds

Cancer advocate speaks at EPA hearing on cancer-causing ethylene oxide: “This proposal will put more people in hospital beds”

Hepatitis B vaccine birth dose down 2% in children under 2 years old, CDC immunization report finds

In Brief

Daniela Matei named director of Houston Methodist Neal Cancer Center

Marshall Posner named associate director, clinical investigations, at TGH Cancer Institute

Christoph Wald elected chair of ACR board of chancellors

Bolyn Hubby named chief of staff at PICI

Carolyn Passaglia, Feng Yue, and Marc Mendillo named to leadership roles at Lurie Cancer Center

Murad Mamedov joins Wistar Institute Center for Advanced Therapeutics

The Mark Foundation for Cancer Research and Samuel Waxman Cancer Research Foundation finalize their merger

University of Maryland Greenebaum CCC receives $3M NCI Career Development Award

NRG Oncology adds new leadership to subcommittees

NCCN Foundation announces recipients of 2026 Young Investigator Awards

Roswell Park brings lung healthcare initiative to indigenous communities across North America

Karmanos Cancer Institute becomes first free-standing cancer center to treat hemophilia B with new gene therapy

Clinical Roundup

IMNN-001 improves median OS by over 14 months in newly diagnosed advanced ovarian cancer, phase II study shows

UVA scientists use AI to improve success rate for new drugs, reduce costs

Small molecule inhibitor blocks prostate cancer bone metastasis

Drugs & Targets

FDA approves Tecartus for r/r mantle cell lymphoma

FDA approves Ponlimsi to increase bone mass, including for breast and prostate cancer patients

FDA grants priority review to Elevar Therapeutics’s lirafugratinib as second-line cholangiocarcinoma treatment

NCI Trials

NCI Trials for April 2026

The National Cancer Institute approved the following clinical research studies last month.

CURRENT ISSUE